Research project: „Double impact of BCL11B gene suppression for the targeted therapy of T-cell neoplasms” has received funding from the First Polish-Chinese Joint Research Call, jointly carried out with the Ministry of Science and Technology of the People’s Republic of China (MOST).
Leader of the project: prof. dr Grzegorz Przybylski, Institute of Human Genetics PAS
A consortium composed of Institute of Human Genetics PAS and Adam Mickiewicz University of Poznań.
